Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Outcomes Beyond 10 Years After Transcatheter Aortic Valve Implantation in High‐Risk Patients With Severe Aortic Valve Stenosis

Title: Outcomes Beyond 10 Years After Transcatheter Aortic Valve Implantation in High‐Risk Patients With Severe Aortic Valve Stenosis
Authors: Dietze, Ellen; Richter, Ines; Dumpies, Oliver; Loria, Johannes Rotta detto; Majunke, Nicolas; Feistritzer, Hans‐Josef; Kiefer, Philipp; Holzhey, David; Noack, Thilo; Linke, Axel; Mangner, Norman; Desch, Steffen; Borger, Michael; Thiele, Holger; Abdel‐Wahab, Mohamed
Source: Catheterization and Cardiovascular Interventions ; volume 106, issue 2, page 1301-1309 ; ISSN 1522-1946 1522-726X
Publisher Information: Wiley
Publication Year: 2025
Collection: Wiley Online Library (Open Access Articles via Crossref)
Description: Background Limited data is available on long‐term outcomes and valve durability measures of transcatheter aortic valve implantation (TAVI). Aims This study sought to assess clinical and echocardiographic outcomes of high‐risk patients during the early experience of TAVI with a follow‐up period extending beyond 10 years. Methods Patients were included who had undergone TAVI at the Heart Center Leipzig between 2006 and 2012. Valve durability measures including moderate and severe structural valve deterioration (SVD) were defined according to the updated standardized definitions of the Valve Academic Research Consortium 3 (VARC‐3). Results A total of 1825 patients were included. The 12‐year mortality rate was 92.8%. At 12 years post‐TAVI, the cumulative incidence of SVD was 9.8% in the total population. Complete echocardiographic follow‐up at ≥ 9 years was available for 56 patients. The median follow‐up of this subgroup was 10.0 years. Moderate SVD was observed in three patients of the echocardiographic follow‐up cohort (5.4%) and severe SVD in two patients (3.6%). Self‐expanding (SE) transcatheter heart valves (THV) had a significantly lower rate of any SVD (2.8% vs 20.0%, p = 0.030) than balloon‐expandable (BE) THV. Conclusion Long‐term mortality rates in high‐risk patients treated with TAVI more than 10 years ago are substantial, which limits assessment of valve durability measures. In a subgroup of survivors beyond 9 years, the cumulative incidence of SVD was low.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1002/ccd.31677
Availability: https://doi.org/10.1002/ccd.31677; https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.31677
Rights: http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.BCD87A87
Database: BASE